Intestinally-restricted Janus Kinase inhibition: a potential approach to maximize the therapeutic index in inflammatory bowel disease therapy

por Beattie, David T., Pulido-Rios, M. Teresa, Shen, Fei, Ho, Melissa, Situ, Eva, Tsuruda, Pam R., Brassil, Patrick, Kleinschek, Melanie, Hegde, Sharath
Publicado 2017

Pharmacological properties of revefenacin (TD‐4208), a novel, nebulized long‐acting, and lung selective muscarinic antagonist, at human recombinant muscarinic receptors and in rat,...

por Hegde, Sharath S., Pulido‐Rios, M. Teresa, Luttmann, Mark A., Foley, James J., Hunsberger, Gerald E., Steinfeld, Tod, Lee, TaeWeon, Ji, Yuhua, Mammen, Mathai M., Jasper, Jeffrey R.
Publicado 2018

Comparative efficacy of AHU-377, a potent neprilysin inhibitor, in two rat models of volume-dependent hypertension

por Hegde, Laxminarayan G, Yu, Cecile, Madhavi, Cheruvu, Araki, Russell, Villarreal, Jennifer, Obedencio, Glenmar, Kanta, Anne, Sandvick, Erik, Hill, Craig, Dement, Kevin, Klein, Uwe, McConn, Donavon, Martin, William, Hegde, Sharath S
Publicado 2011